Left main coronary disease: evolving management concepts
Paul W Armstrong1,2, Eric R Bates3, Mario Gaudino4
1Canadian VIGOUR Centre, University of Alberta, 4-120 Katz Group Centre for Pharmacy and Health Research, Edmonton, AB T6G 2E1, Canada.
European Heart Journal
|September 29, 2022
Summary
Advances in treating left main coronary artery (LMCA) disease offer new options beyond surgery. This review explores optimal medical therapy and percutaneous interventions for LMCA stenosis, especially in complex cases.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Coronary artery disease management has significantly evolved.
- Left main coronary artery (LMCA) disease requires careful consideration due to its critical nature.
- Optimal medical therapy and interventional approaches are increasingly important.
Approach:
- This review examines the comparative benefits of surgical versus percutaneous coronary intervention for LMCA disease.
- It analyzes current treatment strategies for LMCA stenosis, particularly in the 40-69% narrowing range.
- The review also discusses diagnostic challenges and future research directions.
Key Points:
- Percutaneous coronary intervention is a less invasive alternative to coronary artery bypass graft surgery for LMCA disease.
- Optimal medical therapy provides viable treatment choices for selected patients.
- LMCA narrowing between 40-69% presents a complex management scenario requiring individualized assessment.
Conclusions:
- The optimal treatment strategy for LMCA disease depends on individual patient factors and lesion characteristics.
- Further research is needed to clarify diagnostic and therapeutic uncertainties in LMCA disease management.
- Integrating medical therapy, surgical, and interventional approaches enhances patient outcomes.
Keywords:
Coronary artery bypass graftLeft main coronary arteryOptimal medical therapyPercutaneous coronary interventionMore Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
28.1K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.6K
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
17
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
17
01:25Mitral Regurgitation III: Medical Management
25
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
01:29Cardiomyopathy V: Interprofessional Care
29
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
01:25Aortic Regurgitation III: Medical Management
35
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
35
01:26Acute Coronary Syndrome V: Nursing Management
25
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
25
01:28Acute Coronary Syndrome IV: Interprofessional Care
22
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22